Picture of Immuron logo

IMC — Immuron News Story

0.000.00%
au flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

Brief: Immuron Plans Phase 2 Trial For Imm-529 Following FDA Review

Sept 5 (Reuters) - Immuron Ltd  IMC.AX :
    * IMMURON PLANS PHASE 2 TRIAL FOR IMM-529 FOLLOWING FDA
REVIEW
    * IMMURON LTD - IND APPLICATION FOR IMM-529 PLANNED FOR 1H
2025

Source text for Eikon:  ID:nGNXC9vKc 
Further company coverage:  IMC.AX 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Immuron

See all news